Clinicopathologic Characteristics and Clinical Outcomes of OSCC Patients Who Had Positive Findings on Preradiotherapy/CCRT PET/CT Imaging
Prognostic scoring system | ||||||||||
Case no. | Primary cancer site | Primary staging | Extracapsular spread | Lymphatic invasion | Score | Pre-RT/CCRT PET findings | Evidence | Adjuvant treatment modification | Outcomes | Follow-up (mo) |
1 | Left tongue | pT2N0M0 | N | N | 0 | Local, LN (left N3) | Imaging follow-up | Curative CCRT* | NED | 49 |
2 | Right tongue | pT4aN1M0 | N | N | 0 | LN (right, level IV) | Tissue proven | Curative CCRT† | NED | 24 |
3 | Right bucca | pT4aN0M0 | N | N | 0 | Local | Imaging follow-up | Curative CCRT* | NED | 42 |
4 | Left bucca | pT2N0M0 | N | N | 0 | Lung | Imaging follow-up | Palliation | DOD | 4 |
5 | Left tongue | pT3N0M0 | N | N | 0 | Local | Imaging follow-up | Curative CCRT* | NED | 34 |
6 | Left bucca | pT4aN0M0 | N | N | 0 | Local | Imaging follow-up | Curative CCRT* | DOD | 12 |
7 | Right tongue | pT4aN2bM0 | P | N | 1 | LN (left, level V) | Tissue roven | Curative CCRT† | NED | 47 |
8 | Right bucca | pT2N2bM0 | P | N | 1 | Local | Imaging follow-up | Curative CCRT* | NED | 26 |
9 | Right tongue | pT4aN2cM0 | P | N | 1 | LN (left, level IV) | Imaging Follow-up | Curative CCRT† | DOD | 13 |
10 | Right tongue | pT2N2bM0 | P | N | 1 | LN (left, level I, II, III) | Tissue proven | Curative CCRT† | DOD | 16 |
11 | Left tongue | pT2N2bM0 | P | N | 1 | LN (right, level III, V) | Imaging follow-up | Curative CCRT† | NED | 31 |
12 | Right tongue | pT2N2cM0 | P | N | 1 | LN (right, level III, IV) | Tissue proven | Curative CCRT† | DOD | 9 |
13 | Right bucca | pT4aN2bM0 | P | N | 1 | Lung | Imaging follow-up | Palliation | DOD | 2 |
14 | Left bucca | pT3N2bM0 | P | N | 1 | Local, LN (left, level III), lung | Tissue proven | Palliation | DOD | 5 |
15 | Left mouth floor | pT4aN2bM0 | P | N | 1 | Lung | Imaging follow-up | Palliation | DOD | 3 |
16 | Right alveolar ridge | pT4aN1M0 | P | N | 1 | Local | Imaging follow-up | Curative CCRT* | DOD | 8 |
17 | Right bucca | pT4aN2bM0 | P | P | 2 | Local, LN (left, level V and parotid) | Tissue proven | Curative CCRT† | DOD | 4 |
18 | Right bucca | pT4aN2bM0 | P | P | 2 | LN (left, level IV and parotid) | Imaging follow-up | Curative CCRT‡ | DOD | 9 |
19 | Right alveolar ridge | pT3N2bM0 | P | P | 2 | LN (right, level V and left, parotid) | Tissue proven | Curative CCRT† | DOD | 6 |
20 | Left retromolar trigone | pT4aN0M0 | N | N | 0 | Lung score 3§ | Imaging follow-up | Radiotherapy | NED | 36 |
21 | Right buccal | pT4aN0M0 | N | N | 0 | Lung score 3§ | Imaging follow-up | Radiotherapy | NED | 33 |
22 | Right retromolar trigone | pT2N0M0 | N | N | 0 | Local (right mandible, score 3§) | Tissue-proven negative | Radiotherapy | NED | 60 |
23 | Left tongue | pT2N2bM0 | N | P | 1 | LN (right, level II, score 3§), lung, score 3§ | Tissue-proven (LN) negative | Curative CCRT† | DOD (pleural effusion) | 8 |
24 | Left alveolar ridge | pT4aN0M0 | N | N | 0 | Local (left upper gum, score 3§) | Tissue-proven negative | Radiotherapy | NED | 33 |
25 | Left tongue | pT2N2bM0 | P | N | 1 | LN (right level III, V, score 3§) | Tissue-proven negative | Curative CCRT† | NED | 32 |
26 | Right alveolar ridge | pT4aN1M0 | N | N | 0 | LN (right, level V, left SCF, both scores 3§) | Tissue-proven negative | Curative CCRT† | NED | 28 |
↵* Change RT dose; †Change RT dose and field; ‡Change field; §PET/CT score.
ES = extracapsular spread; LI = lymphatic invasion; RT = radiotherapy; N = negative; LN = lymph node; P = positive; NED = no evidence of disease, DOD = died of disease; SCF = supraclavicular fossa.